Cleared Abbreviated

K062893 - KODEA

Also marketed or referenced as:
XJ-2002AS XJ-2003A

K062893 is the FDA 510(k) clearance for KODEA by Shanghai Kodea Economic and Trade Development , Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Abbreviated 510(k) pathway after a 131-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2007
Decision
131d
Days
Class 2
Risk

K062893 is an FDA 510(k) clearance for the KODEA, MODELS XJ-2001AC. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shanghai Kodea Economic and Trade Development , Ltd. (Shanghai, CN). The FDA issued a Cleared decision on February 5, 2007 after a review of 131 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Shanghai Kodea Economic and Trade Development , Ltd. devices

Submission Details

510(k) Number K062893 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2006
Decision Date February 05, 2007
Days to Decision 131 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
6d slower than avg
Panel avg: 125d · This submission: 131d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 513
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K062893.
CLEVER TD-3026 DIGITAL WRIST BLOOD PRESSURE MONITOR, MODEL TD-3026
K073445 · Taidoc Technology Corporation · Apr 2008
1500 PRO
K080289 · Omron Healthcare, Inc. · Feb 2008
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL WATCHBP HOME (BP3MX1-1)
K073198 · Microlife Intellectual Property GmbH · Jan 2008
A&D MEDICAL UA-789 DIGITAL BLOOD PRESSURE MONITOR
K062027 · A&D Engineering, Inc. · Jan 2007
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL BP3MC1-PC
K061471 · Microlife Intellectual Property GmbH · Sep 2006
OMRON AUTOMATIC BLOOD PRESSURE MONITOR WITH COMFIT CUFF, MODEL HEM 780 N3
K061822 · Omron Healthcare, Inc. · Aug 2006